urea has been researched along with quetiapine fumarate in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Brammer, MJ; Brown, RG; Jones, HM; O'Toole, M; Ohlsen, RI; Pilowsky, LS; Purvis, R; Taylor, T; Williams, S | 1 |
Eksanow, K; Glice, M; Kaczmarek, L; Kubiszewski, M; Kutner, A; Stolarczyk, EU | 1 |
Hacksell, U; Hubbard, D; McFarland, K | 1 |
Chitnis, S; Khemani, P; Patel, N; Samudra, N; Womack, KB | 1 |
Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ | 1 |
Cozac, VV | 1 |
Friedman, JH | 1 |
Gandhi, R; Lessig, SL; Litvan, I; Moreno, GM; Nahab, FB; Wright, B | 1 |
Dahodwala, N; Horn, S; Richardson, H; Weintraub, D; Xie, SX | 1 |
Alakkas, A; Liu, L; Longardner, K; Nahab, FB; Wright, BA; Xu, R; You, H | 1 |
3 review(s) available for urea and quetiapine fumarate
Article | Year |
---|---|
Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.
Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Humans; Molecular Targeted Therapy; Neurotransmitter Agents; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Urea | 2016 |
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea | 2017 |
Pharmacological interventions for psychosis in Parkinson's disease patients.
Topics: Antipsychotic Agents; Clozapine; Dopamine; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Urea | 2018 |
1 trial(s) available for urea and quetiapine fumarate
Article | Year |
---|---|
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Brain Mapping; Carbamide Peroxide; Cerebral Cortex; Cognition; Dibenzothiazepines; Drug Combinations; Female; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peroxides; Quetiapine Fumarate; Reaction Time; Schizophrenia; Urea; Verbal Learning | 2004 |
6 other study(ies) available for urea and quetiapine fumarate
Article | Year |
---|---|
Identification and characterization of potential impurities of quetiapine fumarate.
Topics: Aniline Compounds; Antipsychotic Agents; Carbamates; Dibenzothiazepines; Drug Contamination; Magnetic Resonance Spectroscopy; Mass Spectrometry; Phenylurea Compounds; Piperazines; Quetiapine Fumarate; Spectrophotometry, Infrared; Sulfides; Thiazepines; Urea | 2009 |
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios.
Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Parkinsonian Disorders; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Urea | 2013 |
[Modern approaches to treatment of psychosis in Parkinson's disease].
Topics: Antiparkinson Agents; Antipsychotic Agents; Clozapine; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Urea | 2016 |
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Survival Analysis; Treatment Outcome; Urea | 2018 |
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea | 2019 |
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
Topics: Aged; Antipsychotic Agents; Dementia; Humans; Levodopa; Parkinson Disease; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea | 2023 |